AI-Driven Models Enhance Prediction of In-Hospital Mortality for ICU Cancer Patients
Machine learning models, including the CatBoost classifier, show high accuracy in predicting in-hospital mortality among ICU patients with lymphoma, offering valuable insights for personalized risk assessment.
Recent advances in machine learning have demonstrated promising potential in predicting the risk of in-hospital death among ICU patients with lymphoma. A comprehensive study published in PLOS ONE details the development and validation of multiple machine learning models, utilizing data from the Medical Information Mart for Intensive Care IV database. The research involved 1,591 adult ICU patients diagnosed with lymphoma, of whom 342 (21.5%) experienced in-hospital mortality.
The study compared fifteen different machine learning algorithms through receiver operating characteristic and area under the curve (AUC) analyses. Among these, the CatBoost classifier exhibited the highest predictive accuracy with an AUC of 0.7766. Significant predictors identified by the models included blood urea nitrogen (BUN), platelet count, prothrombin time, heart rate, systolic blood pressure, activated partial thromboplastin time, oxygen saturation, and bicarbonate levels.
Particularly noteworthy was the prominent role of BUN, emphasized through SHapley Additive exPlanation (SHAP) analysis, which ranked it as the most influential factor in predicting mortality. The models also provided personalized risk assessments using SHAP force plots, enabling identification of high-risk patient subgroups.
According to the study authors, these machine learning models, especially the CatBoost classifier, could serve as valuable tools for clinicians in estimating mortality risk, supplementing traditional assessment methods. Their interpretability via SHAP analysis offers insights into patient-specific risks, potentially informing more targeted interventions and improving ICU care for lymphoma patients.
This innovative approach highlights the significant role of AI in personalized medicine, ultimately aiming to enhance patient outcomes and clinical decision-making in critical care settings.
Source: https://medicalxpress.com/news/2025-08-ai-hospital-mortality-icu-patients.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative mRNA Vaccine Findings Could Lead to a Universal Cancer Immunotherapy
A groundbreaking study reveals that a novel mRNA vaccine can broadly stimulate the immune system to fight various cancers, paving the way for universal cancer immunotherapy.
Revolutionizing Eye Care: Innovative Approaches for a Brighter Vision Future
Kruti Naik from Wits University is developing cutting-edge microneedle and nanomedicine technologies to improve eye infection treatment, offering safer, more effective solutions to prevent blindness globally.
Expanding Diversity in Family Building Through IVF Advances
Recent IVF data from Australia and New Zealand highlight increased inclusivity and technological advancements, enabling diverse family structures through safer and more effective reproductive options.